HK1049000B - 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物 - Google Patents

異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物 Download PDF

Info

Publication number
HK1049000B
HK1049000B HK03101182.3A HK03101182A HK1049000B HK 1049000 B HK1049000 B HK 1049000B HK 03101182 A HK03101182 A HK 03101182A HK 1049000 B HK1049000 B HK 1049000B
Authority
HK
Hong Kong
Prior art keywords
formula
compound
hydroxy
give
branched
Prior art date
Application number
HK03101182.3A
Other languages
English (en)
Chinese (zh)
Other versions
HK1049000A1 (en
Inventor
M‧威尔兹比克
M‧威爾兹比克
M-F‧博萨德
A‧罗斯奥
M-F‧博薩德
J-A‧布廷
P‧德拉格兰杰
A‧羅斯奧
P‧德拉格蘭傑
Original Assignee
瑟维尔实验室
瑟維爾實驗室
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑟维尔实验室, 瑟維爾實驗室 filed Critical 瑟维尔实验室
Publication of HK1049000A1 publication Critical patent/HK1049000A1/xx
Publication of HK1049000B publication Critical patent/HK1049000B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK03101182.3A 2001-03-12 2003-02-18 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物 HK1049000B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103293 2001-03-12
FR0103293A FR2821843B1 (fr) 2001-03-12 2001-03-12 Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
HK1049000A1 HK1049000A1 (en) 2003-04-25
HK1049000B true HK1049000B (zh) 2005-01-07

Family

ID=8860976

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101182.3A HK1049000B (zh) 2001-03-12 2003-02-18 異吲並吲酮化合物、它們的製備方法和含有它們的藥物組合物

Country Status (24)

Country Link
US (1) US6465660B1 (show.php)
EP (1) EP1241169B1 (show.php)
JP (1) JP3842151B2 (show.php)
KR (1) KR100450313B1 (show.php)
CN (1) CN1159316C (show.php)
AR (1) AR034583A1 (show.php)
AT (1) ATE248171T1 (show.php)
AU (1) AU779702B2 (show.php)
BR (1) BR0200721A (show.php)
CA (1) CA2376876C (show.php)
DE (1) DE60200023T2 (show.php)
DK (1) DK1241169T3 (show.php)
EA (1) EA004035B1 (show.php)
ES (1) ES2206438T3 (show.php)
FR (1) FR2821843B1 (show.php)
HK (1) HK1049000B (show.php)
HU (1) HUP0200913A3 (show.php)
MX (1) MXPA02002601A (show.php)
NO (1) NO20021198L (show.php)
NZ (1) NZ517742A (show.php)
PL (1) PL352750A1 (show.php)
PT (1) PT1241169E (show.php)
SI (1) SI1241169T1 (show.php)
ZA (1) ZA200202030B (show.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT1517909E (pt) * 2002-06-21 2007-01-31 Suven Life Sciences Ltd Novos arilcarbonilindoles tetracíclicos que possuem afinidade para o receptor de serotonina, úteis como agentes terapêuticos, processo para a sua preparação e composições farmacêuticas que os contêm
CA2490115C (en) * 2002-06-21 2009-09-01 Suven Life Sciences Limited Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
EP1567492B1 (en) * 2002-11-28 2013-05-22 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
KR100739987B1 (ko) * 2002-12-18 2007-07-16 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 테트라사이클릭 3-치환인돌
RU2387655C2 (ru) * 2004-08-09 2010-04-27 Бристол-Маерс Сквибб Компани Ингибиторы репликации вируса гепатита с
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
US20240090802A1 (en) 2022-09-02 2024-03-21 Dexcom, Inc. Continuous analyte sensor devices and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377098A (en) * 1976-12-16 1978-07-08 Sumitomo Chem Co Ltd Preparation of indoloisoquinoline derivative
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US5441955A (en) * 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
FR2743365A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indolo(3,2-e)pyrazine-4-one, leur preparation et les medicaments les contenant
WO2002000215A1 (en) * 2000-06-23 2002-01-03 Cognetix, Inc. Subtype selective melatonergics

Also Published As

Publication number Publication date
CN1159316C (zh) 2004-07-28
JP3842151B2 (ja) 2006-11-08
AU779702B2 (en) 2005-02-10
DK1241169T3 (da) 2003-11-24
ZA200202030B (en) 2002-10-03
NO20021198D0 (no) 2002-03-11
HUP0200913A2 (hu) 2002-11-28
ES2206438T3 (es) 2004-05-16
DE60200023T2 (de) 2004-06-03
DE60200023D1 (de) 2003-10-02
FR2821843B1 (fr) 2003-05-09
AR034583A1 (es) 2004-03-03
ATE248171T1 (de) 2003-09-15
JP2002265469A (ja) 2002-09-18
AU2324202A (en) 2002-09-19
HUP0200913A3 (en) 2004-11-29
NZ517742A (en) 2003-02-28
CA2376876A1 (fr) 2002-09-12
CA2376876C (fr) 2006-07-11
KR20020072782A (ko) 2002-09-18
CN1375494A (zh) 2002-10-23
EP1241169A1 (fr) 2002-09-18
NO20021198L (no) 2002-09-13
MXPA02002601A (es) 2004-11-12
PT1241169E (pt) 2003-11-28
PL352750A1 (en) 2002-09-23
HU0200913D0 (show.php) 2002-05-29
US6465660B1 (en) 2002-10-15
KR100450313B1 (ko) 2004-09-30
BR0200721A (pt) 2002-12-03
FR2821843A1 (fr) 2002-09-13
EA004035B1 (ru) 2003-12-25
SI1241169T1 (en) 2003-12-31
HK1049000A1 (en) 2003-04-25
EA200200241A1 (ru) 2002-10-31
EP1241169B1 (fr) 2003-08-27

Similar Documents

Publication Publication Date Title
CN1680284A (zh) 阿戈美拉汀的新合成方法、新晶型及其药物组合物
CN1368960A (zh) 吲哚衍生物、制备它们的方法、含有它们的药用组合物和它们的医疗应用
CN1711260A (zh) 吡啶并嘧啶酮化合物、其制备方法和含有它们的药物
CN1130184A (zh) 新三环酰胺化合物，其制法和含它们的药物组合物
CN1145896A (zh) 新的烷氧芳基化合物，其制备方法和含有它们的药用组合物
CN1100057C (zh) 色烯化合物、其制备方法及含有它们的药物组合物
CN1159316C (zh) 异吲哚并吲哚酮化合物、它们的制备方法和含有它们的药物组合物
CN1185214C (zh) 新的茚并吲哚酮化合物,其制备方法和含有这种化合物的药物组合物
CN1250771A (zh) 具有亚环烷基链的新环状化合物,其制备方法和含有它们的药物组合物
CN1139588C (zh) 新的氟化咪唑啉苯并二噁烷,其制备及其治疗用途
AU2007310769B2 (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CN1050358C (zh) 新四环哌嗪和1,4-噁嗪化合物,其制备和药物组合物
CN1671708A (zh) 新的环烷二酮衍生物、它们的制备方法和它们的药物应用
CN1457337A (zh) 取代的联苯衍生物、制备它们的方法和含有它们的药物组合物
CN1308069A (zh) 取代的(二氢)苯并噁嗪和(二氢)苯并噻嗪化合物,其制法和药物组合物
CN1555377A (zh) 具有抗精神病药活性的2-(氨甲基)-四氢-9-氧杂-1,3-二氮杂-环戊二烯并[a]萘基衍生物
HK1083507A (en) Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
HK1071896A (en) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity
HK1072423A (en) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity
HK1077821A (en) New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
HK1093977A (en) Preparation of 3-azabicyclo [3.1.0] hexane derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100312